Jove
Visualize
联系我们

相关概念视频

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

419
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
419
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

466
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
466
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

821
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
821
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection00:59

Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection

146
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
146
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.8K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

"It's Not a One-Size-Fits-All": Patient Perspectives on Contingency Management and Community Reinforcement Approach for Methamphetamine Use Disorder in Permanent Supportive Housing.

Journal of health care for the poor and underserved·2026
Same author

EHR-Based Social Needs Screening and Referral in Primary Care: Clinician and Staff Perspectives on Practices, Barriers, and Benefits.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.

Nature communications·2026
Same author

A Buprenorphine Retention Report to Measure Opioid Use Disorder Care Metrics and Guide Outreach.

Substance use & addiction journal·2025
Same author

Don't Induct, Just Start Buprenorphine for Opioid Use Disorder.

Journal of general internal medicine·2025
Same author

"The Stars Haven't Aligned": A Mixed-methods Study of Medical Students' Experience With Buprenorphine Training and Subsequent Prescribing During Internship.

Journal of addiction medicine·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Sep 8, 2025

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

448

在低值设置中,只注射重叠布普伦诺芬启动协议.

Richard C Waters1,2, Jeremy Hoog1, Carson Bell1

  • 1Downtown Emergency Service Center, Seattle, Washington.

JAMA network open
|August 15, 2025
PubMed
概括

一个新的注射性布普伦诺芬协议显示,在使用芬太尼的人群中治疗阿片类药物使用障碍 (OUD) 是有前途的,包括那些经历无家可归的人. 在低门设置中,观察到高的启动,完成和保留率.

更多相关视频

Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies
11:02

Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies

Published on: December 1, 2023

1.2K
Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

7.7K

相关实验视频

Last Updated: Sep 8, 2025

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
04:13

Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models

Published on: September 27, 2024

448
Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies
11:02

Author Spotlight: Investigating Cellular and Molecular Dynamics During Muscle Regeneration Using Cutting-Edge Single-Cell Technologies

Published on: December 1, 2023

1.2K
Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

7.7K

科学领域:

  • 成 药物 药物 药物 药物
  • 药理学 药理学是指药理学的学科.
  • 公共卫生 公共卫生

背景情况:

  • 开始治疗阿片类药物使用障碍 (OUD) 的布普伦诺芬对芬太尼使用者来说是个挑战,特别是那些经历无家可归的人.
  • 新的布普伦诺芬启动策略对于这一群体至关重要.

研究的目的:

  • 为了评估一个只注射可用的重叠布普伦诺啡的短期结果,启动协议.
  • 评估该协议在OUD和活跃芬太尼使用者的低门现场环境中的有效性.

主要方法:

  • 使用电子健康记录进行的回顾性观察队列研究 (2024年9月 - 2025年1月).
  • 包括使用芬太尼的中度至重度OUD患者在一个低值的城市OUD治疗计划中.
  • 使用了只注射可用的重叠布普伦诺芬协议,而不需要停止使用芬太尼.

主要成果:

  • 95人符合纳入标准;90%的人启动了协议.
  • 75%的人完成了该方案,64%的人实现了2个月的保留.
  • 研究的人群中,无家可归者占主导地位 (79%).

结论:

  • 只有注射剂的重叠布普伦诺芬协议显示了高的启动,完成和保留率.
  • 这种新的协议是一个有希望的策略,可以在门诊环境中为芬太尼使用者,包括无家可归者,启动布普伦诺芬.
  • 低门,基于现场的护理促进了获得OUD治疗的机会.